Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Department of Pharmacy, Prince of Wales Hospital, Randwick, Australia.
Anaesth Intensive Care. 2023 Sep;51(5):321-330. doi: 10.1177/0310057X231172790.
Opioid analgesics prescribed for the management of acute pain following orthopaedic surgery may lead to unintended long-term opioid use and associated patient harms. This study aimed to examine the prevalence of opioid use at 90 days after elective orthopaedic surgery across major city, regional and rural locations in New South Wales, Australia. We conducted a prospective, observational cohort study of patients undergoing elective orthopaedic surgery at five hospitals from major city, regional, rural, public and private settings between April 2017 and February 2020. Data were collected by patient questionnaire at the pre-admission clinic 2-6 weeks before surgery and by telephone call after 90 days following surgery. Of the 361 participants recruited, 54% (195/361) were women and the mean age was 67.7 years (standard deviation 10.1 years). Opioid use at 90 or more days after orthopaedic surgery was reported by 15.8% (57/361; 95% confidence interval (CI) 12.2-20%) of all participants and ranged from 3.5% (2/57) at a major city location to 37.8% (14/37) at an inner regional location. Predictors of long-term postoperative opioid use in the multivariable analysis were surgery performed at an inner regional location (adjusted odds ratio 12.26; 95% CI 2.2-68.24) and outer regional location (adjusted odds ratio 5.46; 95% CI 1.09-27.50) after adjusting for known covariates. Long-term opioid use was reported in over 15% of patients following orthopaedic surgery and appears to be more prevalent in regional locations in Australia.
在澳大利亚新南威尔士州,接受骨科手术后管理急性疼痛而开具的阿片类镇痛药可能导致非预期的长期阿片类药物使用和相关的患者伤害。本研究旨在检查主要城市、地区和农村地区接受择期骨科手术后 90 天内的阿片类药物使用情况。我们对 2017 年 4 月至 2020 年 2 月期间,来自主要城市、地区、农村、公立和私立医院的 5 家医院接受择期骨科手术的患者进行了前瞻性、观察性队列研究。在手术前 2-6 周的入院前诊所通过患者问卷调查和手术后 90 天的电话随访收集数据。在招募的 361 名参与者中,54%(195/361)为女性,平均年龄为 67.7 岁(标准差 10.1 岁)。361 名参与者中有 15.8%(57/361;95%置信区间[CI]为 12.2-20%)报告在骨科手术后 90 天或以上时间使用阿片类药物,使用范围从主要城市地区的 3.5%(2/57)到内城区的 37.8%(14/37)。多变量分析中,长期术后阿片类药物使用的预测因素包括在城市内部地区(调整后的优势比 12.26;95%CI 2.2-68.24)和城市外部地区(调整后的优势比 5.46;95%CI 1.09-27.50)进行手术,在调整了已知协变量后。骨科手术后 15%以上的患者报告长期使用阿片类药物,且在澳大利亚的地区地点似乎更为普遍。